Stay updated on CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.

Latest updates to the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page
- ChecktodayChange DetectedResults for the study NCT03547999 have been posted on ClinicalTrials.gov. The record now shows a Results First Posted date of 2025-07-22 along with the associated outcome measures.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check29 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

- Check36 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated to v3.0.2; the previous v3.0.1 revision tag and the 'Back to Top' element were removed.SummaryDifference0.1%

- Check58 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%

- Check65 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various medical topics such as colorectal cancer and specific vaccines. Notably, the revision number has been updated to v3.0.0.SummaryDifference2%

Stay in the know with updates to CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.